• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
-Related Congenital Disorder of Deglycosylation-相关糖基化缺陷先天性疾病
2
Two novel compound heterozygous mutations in NGLY1as a cause of congenital disorder of deglycosylation: a case presentation.两个新型 NGLY1 复合杂合突变导致先天性糖基化缺陷症:病例报告。
BMC Med Genet. 2020 Jun 23;21(1):135. doi: 10.1186/s12881-020-01067-1.
3
Aromatic L-Amino Acid Decarboxylase Deficiency芳香族L-氨基酸脱羧酶缺乏症
4
-Related Dopamine Transporter Deficiency Syndrome-相关多巴胺转运体缺乏综合征
5
Urine oligosaccharide screening by MALDI-TOF for the identification of NGLY1 deficiency.基质辅助激光解吸电离飞行时间质谱法尿寡糖筛选用于 NGLY1 缺乏症的鉴定。
Mol Genet Metab. 2018 May;124(1):82-86. doi: 10.1016/j.ymgme.2018.03.002. Epub 2018 Mar 10.
6
IDEDNIK Syndrome伊登尼克综合征
7
NGLY1 deficiency: Novel patient, review of the literature and diagnostic algorithm.N-糖基化酶1缺乏症:新病例、文献综述及诊断算法
JIMD Rep. 2020 Jan 30;51(1):82-88. doi: 10.1002/jmd2.12086. eCollection 2020 Jan.
8
NGLY1 Deficiency: A Rare Newly Described Condition with a Typical Presentation.N-糖基化酶1缺乏症:一种具有典型临床表现的罕见新描述病症。
Life (Basel). 2021 Feb 27;11(3):187. doi: 10.3390/life11030187.
9
Biotinidase Deficiency生物素酶缺乏症
10
Creatine Deficiency Disorders肌酸缺乏症

-相关糖基化缺陷先天性疾病

-Related Congenital Disorder of Deglycosylation

作者信息

Lam Christina, Wolfe Lynne, Need Anna, Shashi Vandana, Enns Gregory

机构信息

University of Washington Seattle Children's Hospital Seattle, Washington

National Institutes of Health Bethesda, Maryland

PMID:29419975
Abstract

CLINICAL CHARACTERISTICS

Individuals with -related congenital disorder of deglycosylation (NGLY1-CDDG) typically display a clinical tetrad of developmental delay / intellectual disability in the mild to profound range, hypo- or alacrima, elevated liver transaminases that may spontaneously resolve in childhood, and a complex hyperkinetic movement disorder that can include choreiform, athetoid, dystonic, myoclonic, action tremor, and dysmetric movements. About half of affected individuals will develop clinical seizures. Other findings may include obstructive and/or central sleep apnea, oral motor defects that affect feeding ability, auditory neuropathy, constipation, scoliosis, and peripheral neuropathy.

DIAGNOSIS/TESTING: The diagnosis of NGLY1-CDDG is established in a proband by the identification of biallelic pathogenic variants in on molecular genetic testing. Typical serum screening tests for congenital disorders of glycosylation (i.e., analysis of serum transferrin glycoforms, N and O glycan profiling) will NOT reliably detect NGLY1-CDDG.

MANAGEMENT

Lubricating eye drops and/or bland ointments for hypolacrima; feeding therapy and/or supplemental tube feeding for those with oromotor deficits and feeding difficulties; adequate access to water and a cool environment (including a cooling vest for those who live in hot climates) for hypohydrosis; vitamin D supplementation for those with vitamin D deficiency; evaluation by a developmental pediatrician and supportive therapies for developmental and cognitive issues; standard treatment for hearing loss, sleep apnea, constipation, scoliosis, and seizure disorder; consideration of referral to a hematologist for abnormal hematologic studies; consideration of referral to a gastroenterologist for elevated liver transaminases. Annual follow up by a pediatrician/internist, rehabilitation medicine specialist, ophthalmologist, neurologist, and nutritionist is recommended. Periodic evaluation by a developmental pediatrician, gastroenterologist/hepatologist, and audiologist should be considered. Hot environment in those with hypohydrosis.

GENETIC COUNSELING

NGLY1-CDDG is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives, prenatal testing for pregnancies at increased risk, and preimplantation genetic testing are possible if the pathogenic variants in the family are known.

摘要

临床特征

患有与去糖基化相关的先天性疾病(NGLY1 - CDDG)的个体通常表现出临床四联征,即轻度至重度的发育迟缓/智力残疾、泪液分泌减少或无泪、儿童期可能自发缓解的肝转氨酶升高,以及一种复杂的运动过度障碍,可包括舞蹈样动作、手足徐动症、张力障碍、肌阵挛、动作性震颤和共济失调性运动。约一半的受影响个体将出现临床癫痫发作。其他发现可能包括阻塞性和/或中枢性睡眠呼吸暂停、影响进食能力的口腔运动缺陷、听觉神经病、便秘、脊柱侧弯和周围神经病。

诊断/检测:通过分子遗传学检测在先证者中鉴定出双等位基因致病性变异来确立NGLY1 - CDDG的诊断。用于先天性糖基化疾病的典型血清筛查试验(即血清转铁蛋白糖型分析、N和O聚糖谱分析)不能可靠地检测出NGLY1 - CDDG。

管理

对于泪液分泌减少,使用润滑眼药水和/或温和眼膏;对于有口腔运动缺陷和进食困难的患者,进行喂养治疗和/或补充管饲;对于少汗症患者,确保充足的饮水和凉爽的环境(对于生活在炎热气候中的患者,包括使用降温背心);对于维生素D缺乏的患者,补充维生素D;由发育儿科医生进行评估并针对发育和认知问题提供支持性治疗;对听力损失、睡眠呼吸暂停、便秘、脊柱侧弯和癫痫症进行标准治疗;对于血液学检查异常的情况,考虑转诊至血液科医生;对于肝转氨酶升高的情况,考虑转诊至胃肠病科医生。建议由儿科医生/内科医生、康复医学专家、眼科医生、神经科医生和营养师进行年度随访。应考虑由发育儿科医生、胃肠病科医生/肝病科医生和听力学家进行定期评估。少汗症患者所处环境应凉爽。

遗传咨询

NGLY1 - CDDG以常染色体隐性方式遗传。在受孕时,受影响个体的每个同胞有25%的机会受到影响,50%的机会成为无症状携带者,25%的机会未受影响且不是携带者。如果家族中的致病性变异已知,则可以对有风险的亲属进行携带者检测、对高风险妊娠进行产前检测以及进行植入前基因检测。